Valion Bio, Inc. (VBIO) SEC filings
VBIO SEC filings moved a median of +0.85% by the close. VBIO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VBIO overview →
27 measured VBIO SEC filing events.
Where these VBIO SEC filings landedvs 25 measured VBIO SEC filing reactions
| Middle 50% of VBIO SEC filing reactions | -5.84% to +6.25% |
|---|---|
| Median reaction (to close) | +0.85% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 VBIO SEC filing events with a measured close landed between -5.84% and +6.25%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEF 14A Valion Bio, Inc. For: Nov 12 | SEC filing · Form DEF | — | — | |
| Form S-3 Valion Bio, Inc. | SEC filing · Form S-3 | — | — | |
| Form 8-K Valion Bio, Inc. For: Oct 15 | SEC filing · Form 8-K | +1.80% | +10.81% | |
| Form 8-K Valion Bio, Inc. For: Oct 14 | SEC filing · Form 8-K | -1.86% | -5.84% | |
| Form 8-K Valion Bio, Inc. For: Oct 07 | SEC filing · Form 8-K | +3.87% | +6.76% | |
| Form S-3 Valion Bio, Inc. | SEC filing · Form S-3 | +3.87% | +6.76% | |
| Form 8-K Valion Bio, Inc. For: Oct 05 | SEC filing · Form 8-K | +0.00% | +0.85% | |
| Form PRE 14A Valion Bio, Inc. For: Oct 02 | SEC filing · Form PRE | -2.46% | +2.48% | |
| Form 8-K Valion Bio, Inc. For: Sep 30 | SEC filing · Form 8-K | +3.92% | -1.57% | |
| Form 8-K Valion Bio, Inc. For: Sep 17 | SEC filing · Form 8-K | -1.31% | +11.43% | |
| Form 8-K Valion Bio, Inc. For: Aug 27 | SEC filing · Form 8-K | +1.61% | -4.66% | |
| Form 8-K Valion Bio, Inc. For: Aug 26 | SEC filing · Form 8-K | -3.09% | -19.29% | |
| Form RW Valion Bio, Inc. | SEC filing · Form RW | +0.75% | +38.33% | |
| Form 8-K/A Valion Bio, Inc. For: Aug 14 | SEC filing · Form 8-K | +0.00% | +2.17% | |
| Form 8-K Valion Bio, Inc. For: Aug 14 | SEC filing · Form 8-K | -1.90% | +5.31% | |
| Form 10-Q Valion Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.90% | +5.31% | |
| Form EFFECT Valion Bio, Inc. | SEC filing · Form EFFECT | +6.25% | +6.75% | |
| Form 8-K Valion Bio, Inc. For: Jul 31 | SEC filing · Form 8-K | +4.42% | +0.88% | |
| Form DEF 14A Valion Bio, Inc. For: Aug 14 | SEC filing · Form DEF | +0.00% | -20.81% | |
| Form S-1 Valion Bio, Inc. | SEC filing · Form S-1 | +0.00% | -20.81% | |
| Form 8-K Valion Bio, Inc. For: Jul 14 | SEC filing · Form 8-K | -0.41% | -4.63% | |
| Form PRE 14A Valion Bio, Inc. For: Aug 14 | SEC filing · Form PRE | +0.30% | -3.33% | |
| Form 8-K Valion Bio, Inc. For: Jun 17 | SEC filing · Form 8-K | -1.55% | -8.68% | |
| Form S-8 Valion Bio, Inc. | SEC filing · Form S-8 | +0.00% | +6.25% | |
| Form 8-K Valion Bio, Inc. For: May 28 | SEC filing · Form 8-K | -4.48% | -3.73% | |
| Form 10-Q Valion Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.09% | -9.28% | |
| Form 8-K Valion Bio, Inc. For: May 14 | SEC filing · Form 8-K | -3.09% | -9.28% |
Keep exploring
More VBIO: earnings → · analyst actions → · VBIO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VITROLIFE AB UNSP/ADR (VTRLY) | 50 | 0.00% | 0% |
| Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) | 49 | -0.01% | 17% |
| Advaxis, Inc. (ADXS) | 48 | 0.00% | 21% |
| Arch Biopartners Inc (ARCH_CDNX) | 48 | -0.59% | 19% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.